Site Search
Displaying results 51 - 60 of 184
Resource | Publications,
The HIV epidemic amongst men who have sex with men (MSM) in Bangkok is substantial. The population size of MSM in Bangkok is 120,000-250,000, with approximately one-third (33.5 percent) considered high-risk, characterized by their young age, multiple partnerships, frequent unprotected anal intercourse, and sexual activities around MSM hotspots. In metropolitan Bangkok, HIV prevalence among MSM reportedly increased from 21 percent to 28 percent between 2000 and 2012. The Thai Working Group of Estimation and Projection (2013) projected an estimate of 39,000 new HIV infections would occur in Thailand during 2012-2016, based on the AIDS Epidemic Model (AEM).
Resource | Publications,
Founded in 2002, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is one of the world’s largest multilateral health funders, disbursing $3–$4 billion a year across 100-plus countries.
Many researchers and policymakers have hypothesized that models tying grant payments to achieved and verified results—referred to in this report as next generation financing models—offer an opportunity for the Global Fund to push forward its strategic interests and accelerate the impact of its investments. Realizing their potential requires technical know-how and careful, strategic decisionmaking that responds to specific country and epidemiological contexts—all with little evidence or experience to guide the way.
This report addresses the how of next generation financing models that is, the concrete steps needed to change the basis of payment from expenses to something else: outputs, outcomes, or impact.
Resource | Presentations,
Asia Pacific Intergovernmental Meeting on HIV and AIDS
Bangkok, Thailand
29 January 2015
Resource | Publications,
This analysis was done to estimate the required investments in the future to respond to HIV and AIDS in a cost-effective and optimal manner.
The result of the Investment Case Analysis (ICA) has been reviewed by all stakeholders involved in the national technical team which comprised the Ministry of Health, the National AIDS Commission, and development partners like DFAT, WHO and UNAIDS. The results of this review are based on an analysis of the best and most current data available as of September 2014 in terms of HIV epidemic data, the 2013 IBBS for category B districts, the 2013 Papua IBBS, and revised 2014 unit cost for treatment. Analysis obtained from the study results has also guided the selection of the optimal scenario for the National HIV and AIDS Strategy and Action Plan 2015-2019 and informed the preparation of Indonesia’s Global Fund New Funding Model Concept note in 2015.
Resource | Publications,
We have made incredible progress in the global fight against HIV/AIDS. But we are starting to see a dangerous level of complacency which threatens to reverse the real achievements made so far.
The world stands at a critical juncture: if we act with urgency in the next five years, we could end AIDS as an epidemic by 2030. But achieving this goal will require $12 billion annually more by 2020, targeted more effectively to reach the most vulnerable. Our new report calls on governments to prioritize support for the Global Fund; leaders in sub-Saharan Africa to invest more domestic resources in health; and the private sector to play a greater role.
Resource | Publications,
As world leaders meet to discuss the future of financing for development1, this report from the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the Kaiser Family Foundation finds that funding to address HIV in low- and middle-income countries from nine of fourteen donor governments assessed either declined or remained flat in 2014; funding from five governments increased. Donor government funding for HIV overall grew by less than 2 percent, totaling US$8.64 billion in 2014. After adjusting for inflation and exchange rate changes, the increase was marginal (1%). Still, this was its highest level to date. Most of the increase in HIV funding in 2014 can be attributed to the United Kingdom, without which overall disbursements would have dropped. In addition, contributions to Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), an increasing channel of HIV support for some donors over time, went up overall, while bilateral funding went down. Funding from the United States, the largest donor to HIV in the world, was essentially flat.
Resource | Publications,
In its eleventh annual report, the HIV Vaccines and Microbicides Resource Tracking Working Group (the “Working Group”) documents biomedical HIV prevention research and development (R and D) spending for the calendar year 2014, as well as reports on an analysis of investment trends spanning fourteen years. The Working Group generates estimates of R and D investment that can be compared year to year across options and strategies and funding sources, helping assess the impact of public policies aimed at accelerating scientific progress and to provide facts for advocacy. This effort provides transparency for funders, policy makers and HIV/AIDS advocates so they can better understand and track investment flows.
Resource | Publications,
This report examines the resource challenges that confront the AIDS response in Asia and the Pacific. It proposes a set of interventions that will help overcome them and steer the region towards ending its AIDS epidemic.
The report summarizes the analysis done by an independent, expert advisory panel on AIDS funding in Asia and the Pacific, convened jointly by UNAIDS and the World Bank in August 2013. The Expert Panel was tasked with reviewing the prospects for ending the region’s AIDS epidemic in the context of changing global economy and external funding environment.
Resource | Reviews and Snapshots,
Papua New Guinea is one of the twelve highest HIV burden countries in Asia and the Pacific region with an estimated 32,000 people living with HIV in 2013. There were an estimated 2,200 new HIV infections – a 31% decline since 2005. As of June 2014, 16,773 people were receiving antiretroviral therapy, and prevention of mother-to-child transmission coverage was 41% (35%-47%) in 2013.
Resource | Publications,
This paper is an offshoot of the 2014 AIDS Epidemic Model (AEM) Report endorsed by the Department of Health in August 2014. The AEM report utilized a set of tools (AEM workbooks) that provided techniques for estimating and measuring the impact of past and future programs on the HIV epidemic in the Philippines (1970-2050).